Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | F11 | P03951 | 1/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710110 | 0.90 | GRIK1 (0.32) | GRIK1GPR35F11KLKB1 | |
| SCHEMBL6707814 | 0.89 | GRIK1 (0.33) | GRIK1GPR35F11KLKB1 | |
| SCHEMBL6710260 | 0.89 | GRIK1 (0.38) | GRIK1GPR35F11 | |
| SCHEMBL6709886 | 0.88 | GRIK1 (0.42) | GRIK1F11KLKB1 | |
| SCHEMBL6710244 | 0.84 | PARP14 (0.34) | GRIK1GPR35 | |
| SCHEMBL6708831 | 0.84 | GRIK1 (0.36) | GRIK1F11KLKB1 | |
| SCHEMBL6707739 | 0.84 | — | — | |
| SCHEMBL6709930 | 0.82 | PARP14 (0.37) | GPR35 | |
| SCHEMBL6711649 | 0.79 | GRIK1 (0.33) | GRIK1F11KLKB1 | |
| SCHEMBL6708719 | 0.79 | GRIK1 (0.38) | GRIK1GPR35F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
| WO-2004018461-A2 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | GRIK1 3885/4885GPR35 2928/4885F11 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.